News

Several tech and political leaders have called for a pause on the development of advanced AI. While that is wishful thinking at best, "AI loser" Adobe is a "Buy" anyway.

Accenture plc (NYSE:ACN) investors are having a rough year, with the shares down more than 25%. Now Wall Street is divided over the company’s outlook. Morgan Stanley raised its price target on Accenture to $175 from $130 on September 14. Accenture shares soared more than 6% in afternoon trading following the price target increase, even […]

AI safety just moved from theory to big-ticket budget line as Anthropic and Accenture commit at least US$1b to third party model evaluation. That kind of spending can reshape where governance, risk and compliance money flows. Ignore it and you risk missing where a fresh cluster of contracts and partnerships could appear. This article spotlights three stocks exposed to that news and explains why each might warrant closer attention. The stocks highlighted below are only a first cut and the full...

Shares of global professional services company Accenture (NYSE:ACN) fell 3.3% in the afternoon session after Guggenheim analyst Jonathan Lee downgraded the stock to Neutral. According to StreetInsider, the rating change shifted Guggenheim's stance on the professional services firm from a previously bullish position. Downgrades from prominent research analysts often prompt institutional and retail investors to reassess their positions, leading to increased selling volume. A Neutral rating typical

Accenture (ACN) closed at $181.29 in the latest trading session, marking a -4.73% move from the prior day.

Accenture is about to take on its most high-risk consulting engagement ever.

Accenture stock jumps as Anthropic announces plans to partner with the technology consulting firm on AI safety evaluations.

The partnership will put independent evaluators inside Anthropic to assess models, test safeguards, and conduct alignment reviews.

Accenture shares climbed nearly 9% in aftermarket trading. The technology consulting company announced a partnership with Anthropic Friday afternoon. The firm is establishing a team of "embedded evaluators" to work with Anthropic's internal teams in stress testing models, safeguards and alignment.

Anthropic PBC is partnering with Accenture Plc, a management and technology consulting company, to test the safety of its advanced artificial intelligence models by embedding evaluators from the consulting firm directly within its operations.

Accenture (ACN) stock has gone down for a year while the market has gone up. At around $190, it sits toward the cheap end of its own ten-year history on earnings. The risk sits in what those earnings are made of.

Guggenheim sees slowing consulting demand and a premium valuation leaving little room for disappointment ahead of Accenture’s October earnings, says report.

Shares of Accenture drop after catching a downgrade from Guggenheim over concerns weaker demand didn’t justify the stock’s recent rally.

Accenture offers steady growth, a growing dividend, and deep enterprise relationships. Micron offers exposure to one of the most powerful demand trends in semiconductors right now.

Accenture has seen its share price move around in recent years, and that raises a simple question for you as an investor. Is the current US$190.29 price tag aligned with the cash the business is expected to generate over time, based on a Discounted Cash Flow (DCF) view of its value? Over the past 5 years the stock has fallen 39%, which puts extra focus on whether the current valuation is still grounded in the cash flows the company can plausibly produce. The new Gemini Enterprise Business...

Aristotle International Equity Fund, sub-advised by Aristotle Capital Management, LLC, released its second-quarter 2026 investor letter. The letter can be downloaded here. Global equity markets reached record highs in Q2, with the MSCI ACWI Index rising 14.93%, while global fixed income grew modestly by 0.87%. Geopolitical tensions, particularly in the Middle East, affected energy markets […]

CFO JOURNAL NEWSLETTER Good morning. Financial services are being retooled in the age of artificial intelligence, which is reflected in corporate boardrooms. I recently met with Craig Richey of consulting firm Accenture and the software company BlackLine’s CFO Patrick Villanova, who both spoke about what they say is an evolving landscape.

FEATURE Stock futures were rising on Friday, as investors carried on piling into tech following the Federal Reserve’s first interest-rate increase in more than three years. The artificial-intelligence trade still has legs, judging by premarket moves.

Accenture (ACN) stock has returned 50% since the middle of June, while the S&P 500 returned about 1%. Even after that run, near $190, it sits about a third below its 52-week high. The run started at $126.46, just above the 52-week low, so part of the gain is a bounce. Even so, a move that big usually follows a quarter that changed something. Accenture's last results came on June 18, the day this run began, and it has not reported a quarter since.

International Business Machines (IBM) shares trade near $237, and options price a one-year range around that from $161.75 to $348.69. That band is the calmer version of this stock. Over the past year IBM moved harder than its options now assume. The business question hanging over IBM comes from the second quarter of 2026: whether the software deals that slipped were delayed or lost.

Here’s a roundup of numbers from the last week — including how many employers say artificial intelligence is actually slowing down the hiring process.

Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.

Leidos has trailed the broader market over the past year, although analysts remain cautiously optimistic about its prospects.

Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a worry, these businesses can invest more in growth, innovation, or buybacks and dividends.

In the most recent trading session, Accenture (ACN) closed at $189.64, indicating a -1.94% shift from the previous trading day.

The consulting giant returned significant capital to shareholders even as its share price declined. Here is the accounting of what owners actually got, and what they might get next.

An analysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) […]

Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the “Multi Cap Equity Fund”. The letter can be downloaded here. The Multi Cap Equity Fund’s Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index’s 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East […]

Accenture (NYSE: ACN) has agreed to pay US$25 million to settle U.S. Department of Justice discrimination claims tied to federal contracts. The settlement resolves allegations that Accenture violated federal contract requirements related to employment practices for government work. Accenture reached the agreement with the DOJ without a court judgment, addressing claims focused on compliance with U.S. contractor rules. The US$25 million DOJ discrimination settlement is important, but...

Check out the companies making headlines yesterday: